Chembio Diagnostics and Takeda Pharmaceutical Complete Feasibility Study
11 mars 2020 16h10 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., March 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it...
Chembio Diagnostics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
03 mars 2020 17h42 HE
|
Chembio Diagnostics, Inc.
MEDFORD, March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release...
Chembio Diagnostics Provides Update on Regulatory Status of DPP HIV-Syphilis System
03 mars 2020 08h30 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, is providing an update on the...
Chembio Diagnostics Receives $1.5 Million UNICEF Order for Multiplex Zika Systems
12 févr. 2020 07h45 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a $1.5 million...
Chembio Diagnostics Announces CEO Transition
09 janv. 2020 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced President and...
Chembio Diagnostics Provides Update on FDA Submission of DPP HIV-Syphilis Test
02 janv. 2020 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today provided an update on its...
Chembio Diagnostics Completes Acquisition of Orangelife
25 nov. 2019 16h30 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has...
Chembio Diagnostics to Participate in Upcoming Investor Conferences
14 nov. 2019 16h40 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company...
Chembio Diagnostics Reports Third Quarter 2019 Financial Results
07 nov. 2019 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Enters into Definitive Agreement to Acquire Orangelife
07 nov. 2019 16h03 HE
|
Chembio Diagnostics, Inc.
Acquisition will expand commercial presence and market opportunity in Brazil MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care...